Breaking Finance News

BidaskClub downgraded Davita Inc (NYSE:DVA) to Sell in a statement released earlier today.

BidaskClub has downgraded Davita Inc (NYSE:DVA) to Sell in a statement released on Saturday July 08, 2017.

Having a price of $63.42, Davita Inc (NYSE:DVA) traded 0.75% higher on the day. With the last close down -13.88% from the two hundred day average, compared with the Standard & Poor's 500 Index which has increased 0.05% over the same period. DVA has recorded a 50-day average of $62.89 and a two hundred day average of $65.66. Trade Volume was down over the average, with 1,332,485 shares of DVA changing hands under the typical 1,521,470

Recent Performance Chart

Davita Inc (NYSE:DVA)

Davita Inc has PE ratio of 8.61 with a one year low of $54.50 and a one year high of $70.16 and has a market capitalization of $0.

A total of 9 analysts have released a report on Davita Inc. Four analysts rating the company a strong buy, one analyst rating the company a buy, seven analysts rating the company a hold, one analyst rating the company a underperform, and finally zero analysts rating the company a sell with a 12-month price target of $77.00.

General Company Details For Davita Inc (NYSE:DVA)

DaVita Inc., formerly DaVita HealthCare Partners Inc., operates two divisions: DaVita Kidney Care (Kidney Care) and DaVita Medical Group (DMG). The Kidney Care division consists of its the United States dialysis and related lab services, its ancillary services and strategic initiatives, including its international operations, and its corporate administrative support. Its DMG division is a patient- and physician-focused integrated healthcare delivery and management company that provides medical services to members through capitation contracts. Its segments include U.S. dialysis and related lab services, DMG, and Other-Ancillary services and strategic initiatives. Its U.S. dialysis and related lab services line of business provide kidney dialysis services in the United States for patients suffering from chronic kidney failure, also known as end stage renal disease (ESRD). As of December 31, 2016, it had operated or provided administrative services to 154 outpatient dialysis centers.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.